,/B.

Aditi Sharma1, Ashim Das1, Amanjit Bal1

  • 1Department of Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

PubMed
概括

在扩散性大B细胞淋巴瘤 (DLBCL) 中识别突变可以预测治疗结果. 特定的基因突变,如NOTCH1和TNFAIP3,与DLBCL患者的反应不佳和复发有关.